Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms

NCT02001714 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 463

Last updated 2017-10-19

Study results available
· View outcomes & findings →

Summary

This three-site randomized controlled trial compares the effectiveness and cost-effectiveness of a group-administered behavioral treatment program to no treatment. Women with stress, urgency, or mixed urinary incontinence will be recruited and screened centrally, evaluated clinically at each of three study sites, and random assigned to one of two treatment arms: 1. Group behavioral treatment or 2. No treatment. Group treatment modalities have the potential to reach a larger population of older women with urinary incontinence, not only in the traditional medical settings, but also in community settings. The investigators hypothesize that group behavioral treatment will be more effective than no treatment. The investigators hypothesize that the group treatment will be cost-effective compared to no treatment.

Conditions

  • Urinary Incontinence, Stress
  • Urinary Incontinence, Urge

Interventions

BEHAVIORAL

Group Behavioral Treatment

Group Behavioral Treatment class is a two hour class taught by certified interventionist covering urinary system anatomy, bladder health and self management strategies, pelvic floor training, pelvic floor muscle contracting techniques, and bladder training. Slides and handouts supplement the content of the class.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH
  • Ananias Diokno

    lead OTHER

Principal Investigators

  • Ananias C Diokno, MD · William Beaumont Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02001714 on ClinicalTrials.gov